Understand and overcome the challenges associated with conducting childhood, adolescent and young adult (CAYA) cancer research in Canada by bridging the gaps that occur when moving a promising idea through the various stages of discovery and into clinical trials.


Address and remove the barriers that exist in accessing targeted and promising cancer clinical trials for CAYA with cancer in Canada.


Educate and activate government leaders, policy makers, industry and others active in the Canadian medical community to effectively address the issues facing CAYA cancer oncologists, researchers, patients and their families to better improve and streamline access to innovative treatments.


Connect with CAYA health advocacy groups across Canada to strengthen our collective voice in fighting for world class care for children, adolescents and young adults with cancer.


Ac2orn Goals.

June 6, 2018:
31 cancer organizations and 30 leading pediatric oncologists and researchers across North America have now signed the proposal.  [Updated version as of June 6, 2018.]


May 17, 2018:
Over 23 leading pediatric oncologists and researchers, and 27 cancer organizations from across North America, are shedding light on the inequitable access to promising early phase clinical trials for Canadian children, adolescents and young adults (CAYA) with cancer and offering solutions to ensure no child gets left behind.

Authored by Advocacy for Canadian Childhood Oncology Research Network (Ac2orn), with assistance from the C17 Council and Helena’s Hope: Pathways to More Kids Surviving Cancer, the proposal “Improving Outcomes for Canadian Children, Adolescents, and Young Adults with Cancer: A proposal for a working relationship with Health Canada”, provides actionable feedback from researchers and clinicians across the country.


Please see the Media page for more information.


Ac2orn News.

Ac2orn Mission.

We are committed to advocating for translational research and effective treatments to realize the goal of curing childhood, adolescent, and young adult cancers.